{"abstract":"The National Cancer Institute (NCI), an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to Australian National University (\"ANU\"), a non-profit research institution located in Canberra, Australia for NCI's rights to the patent applications listed in the Supplementary Information section of this notice.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2023/05/05/2023-09566.html","cfr_references":[],"citation":"88 FR 29141","comment_url":null,"comments_close_on":"2023-05-22","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Cancer Institute's Technology Transfer Center on or before May 22, 2023 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2023-09566","effective_on":null,"end_page":29142,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2023/05/05/2023-09566.xml","html_url":"https://www.federalregister.gov/documents/2023/05/05/2023-09566/prospective-grant-of-an-exclusive-patent-license-predicting-patient-response-to-cancer-therapy-via","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2023-09566?publication_date=2023-05-05","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2023-05-05/2023-09566/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":141,"last_updated":"2026-10-25 08:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2023-05-05/pdf/2023-09566.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2023-09566.pdf?1683204324","publication_date":"2023-05-05","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2023/05/05/2023-09566.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-05-05T08:20:31Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":29141,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License: Predicting Patient Response to Cancer Therapy via Histopathology Images","toc_doc":"Prospective Grant of an Exclusive Patent License; Predicting Patient Response to Cancer Therapy via Histopathology Images","toc_subject":"Licenses; Exemptions, Applications, Amendments etc.:\n","topics":[],"type":"Notice","volume":88}